125 related articles for article (PubMed ID: 35342085)
1. Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy.
Xolalpa-Cueva L; García-Carlos CA; Villaseñor-Zepeda R; Orta-Salazar E; Díaz-Cintra S; Peña-Ortega F; Perry G; Mondragón-Rodríguez S
J Alzheimers Dis; 2022; 87(2):529-543. PubMed ID: 35342085
[TBL] [Abstract][Full Text] [Related]
2. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
3. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
4. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model.
Bailey RM; Howard J; Knight J; Sahara N; Dickson DW; Lewis J
Mol Neurodegener; 2014 Jan; 9():8. PubMed ID: 24428919
[TBL] [Abstract][Full Text] [Related]
5. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
Yue M; Hanna A; Wilson J; Roder H; Janus C
Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
[TBL] [Abstract][Full Text] [Related]
6. Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).
Kim J; Choi IY; Duff KE; Lee P
Neurochem Res; 2017 Jun; 42(6):1649-1660. PubMed ID: 28523532
[TBL] [Abstract][Full Text] [Related]
7. Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
Parka A; Volbracht C; Hall B; Bastlund JF; Nedergaard M; Laursen B; Botta P; Sotty F
J Alzheimers Dis; 2023; 93(1):247-262. PubMed ID: 37005884
[TBL] [Abstract][Full Text] [Related]
8. Cornel Iridoid Glycoside Suppresses Tau Hyperphosphorylation and Aggregation in a Mouse Model of Tauopathy through Increasing Activity of PP2A.
Ma D; Luo Y; Huang R; Zhao Z; Wang Q; Li L; Zhang L
Curr Alzheimer Res; 2019; 16(14):1316-1331. PubMed ID: 31902362
[TBL] [Abstract][Full Text] [Related]
9. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy.
Wang X; Smith K; Pearson M; Hughes A; Cosden ML; Marcus J; Hess JF; Savage MJ; Rosahl T; Smith SM; Schachter JB; Uslaner JM
PLoS One; 2018; 13(4):e0195486. PubMed ID: 29624602
[TBL] [Abstract][Full Text] [Related]
10. Progressive functional impairments of hippocampal neurons in a tauopathy mouse model.
Ciupek SM; Cheng J; Ali YO; Lu HC; Ji D
J Neurosci; 2015 May; 35(21):8118-31. PubMed ID: 26019329
[TBL] [Abstract][Full Text] [Related]
11. Cornel Iridoid Glycoside Suppresses Hyperactivity Phenotype in rTg4510 Mice through Reducing Tau Pathology and Improving Synaptic Dysfunction.
Ma DL; Luo Y; Huang R; Zhao ZR; Zhang L; Li YL; Wang Q; Li L; Zhang L
Curr Med Sci; 2020 Dec; 40(6):1031-1039. PubMed ID: 33428130
[TBL] [Abstract][Full Text] [Related]
12. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
13. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.
Boekhoorn K; Terwel D; Biemans B; Borghgraef P; Wiegert O; Ramakers GJ; de Vos K; Krugers H; Tomiyama T; Mori H; Joels M; van Leuven F; Lucassen PJ
J Neurosci; 2006 Mar; 26(13):3514-23. PubMed ID: 16571759
[TBL] [Abstract][Full Text] [Related]
14. Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy.
Booth CA; Witton J; Nowacki J; Tsaneva-Atanasova K; Jones MW; Randall AD; Brown JT
J Neurosci; 2016 Jan; 36(2):350-63. PubMed ID: 26758828
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.
Holton CM; Hanley N; Shanks E; Oxley P; McCarthy A; Eastwood BJ; Murray TK; Nickerson A; Wafford KA
Alzheimers Res Ther; 2020 Jul; 12(1):84. PubMed ID: 32669112
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
Mondragón-Rodríguez S; Salas-Gallardo A; González-Pereyra P; Macías M; Ordaz B; Peña-Ortega F; Aguilar-Vázquez A; Orta-Salazar E; Díaz-Cintra S; Perry G; Williams S
J Biol Chem; 2018 Jun; 293(22):8462-8472. PubMed ID: 29632073
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment.
Hatch RJ; Wei Y; Xia D; Götz J
Acta Neuropathol; 2017 May; 133(5):717-730. PubMed ID: 28091722
[TBL] [Abstract][Full Text] [Related]
18. Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice.
Yanagisawa D; Hamezah HS; Pahrudin Arrozi A; Tooyama I
Sci Rep; 2021 May; 11(1):9623. PubMed ID: 33953293
[TBL] [Abstract][Full Text] [Related]
19. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5.
Yanagisawa D; Hamezah HS; Durani LW; Taguchi H; Tooyama I
PLoS One; 2018; 13(12):e0208440. PubMed ID: 30521594
[TBL] [Abstract][Full Text] [Related]
20. TAPPing into the potential of inducible tau/APP transgenic mice.
Xu G; Ulm BS; Howard J; Fromholt SE; Lu Q; Lee BB; Walker A; Borchelt DR; Lewis J
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12791. PubMed ID: 35067965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
